Deferiprone Market to Reach $45.9 Billion by 2033 Globally, at 3.2% CAGR: Allied Market Research

Rising prevalence of transfusion-dependent anemias, increasing awareness of iron overload complications, and growing preference for oral iron chelation therapies are the major factors which drive the global deferiprone market growth. WILMINGTON, Del., Feb. 17, 2026 /PRNewswire/ -- Allied...